共 323 条
- [1] Shin A(2011)Gastric cancer epidemiology in Korea Journal of Gastric Cancer 11 135-140
- [2] Kim J(2010)Bortezomib synergizes TRAIL-induced apoptosis in gastric cancer cells Digestive Diseases and Sciences 55 3361-3368
- [3] Park S(2012)Targeted therapy for gastric cancer Current Treatment Options in Oncology 13 377-389
- [4] Liu J(2013)Molecular targeted therapies in advanced gastric cancer: Does tumor histology matter? Therapeutic Advances in Gastroenterology 6 15-31
- [5] Qu XJ(2013)Molecular profiling of gastric cancer: Toward personalized cancer medicine Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31 838-839
- [6] Xu L(2010)Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer British Journal of Cancer 102 506-512
- [7] Zang Y(2008)Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer Lung Cancer 61 82-90
- [8] Qu JL(2010)A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin’s lymphoma British Journal of Cancer 103 1783-1787
- [9] Hou KZ(2010)Reovirus infection induces apoptosis of TRAIL-resistant gastric cancer cells by down-regulation of Akt activation International Journal of Oncology 36 1023-1030
- [10] Liu YP(2003)Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers Cancer Science 94 1066-1073